23028965|t|Stability of the transthyretin molecule as a key factor in the interaction with a-beta peptide--relevance in Alzheimer's disease.
23028965|a|Transthyretin (TTR) protects against A-Beta toxicity by binding the peptide thus inhibiting its aggregation. Previous work showed different TTR mutations interact differently with A-Beta, with increasing affinities correlating with decreasing amyloidogenecity of the TTR mutant; this did not impact on the levels of inhibition of A-Beta aggregation, as assessed by transmission electron microscopy. Our work aimed at probing differences in binding to A-Beta by WT, T119M and L55P TTR using quantitative assays, and at identifying factors affecting this interaction. We addressed the impact of such factors in TTR ability to degrade A-Beta. Using a dot blot approach with the anti-oligomeric antibody A11, we showed that A-Beta formed oligomers transiently, indicating aggregation and fibril formation, whereas in the presence of WT and T119M TTR the oligomers persisted longer, indicative that these variants avoided further aggregation into fibrils. In contrast, L55PTTR was not able to inhibit oligomerization or to prevent evolution to aggregates and fibrils. Furthermore, apoptosis assessment showed WT and T119M TTR were able to protect against A-Beta toxicity. Because the amyloidogenic potential of TTR is inversely correlated with its stability, the use of drugs able to stabilize TTR tetrameric fold could result in increased TTR/A-Beta binding. Here we showed that iododiflunisal, 3-dinitrophenol, resveratrol, [2-(3,5-dichlorophenyl)amino] (DCPA) and [4-(3,5-difluorophenyl)] (DFPB) were able to increase TTR binding to A-Beta; however only DCPA and DFPB improved TTR proteolytic activity. Thyroxine, a TTR ligand, did not influence TTR/A-Beta interaction and A-Beta degradation by TTR, whereas RBP, another TTR ligand, not only obstructed the interaction but also inhibited TTR proteolytic activity. Our results showed differences between WT and T119M TTR, and L55PTTR mutant regarding their interaction with A-Beta and prompt the stability of TTR as a key factor in this interaction, which may be relevant in AD pathogenesis and for the design of therapeutic TTR-based therapies.
23028965	17	30	transthyretin	Gene	7276
23028965	109	128	Alzheimer's disease	Disease	MESH:D000544
23028965	130	143	Transthyretin	Gene	7276
23028965	145	148	TTR	Gene	7276
23028965	167	173	A-Beta	Gene	351
23028965	174	182	toxicity	Disease	MESH:D064420
23028965	270	273	TTR	Gene	7276
23028965	310	316	A-Beta	Gene	351
23028965	397	400	TTR	Gene	7276
23028965	460	466	A-Beta	Gene	351
23028965	581	587	A-Beta	Gene	351
23028965	595	600	T119M	ProteinMutation	tmVar:p|SUB|T|119|M;HGVS:p.T119M;VariantGroup:1;CorrespondingGene:7276;CorrespondingSpecies:9606
23028965	605	609	L55P	ProteinMutation	tmVar:p|SUB|L|55|P;HGVS:p.L55P;VariantGroup:0;CorrespondingGene:7276;CorrespondingSpecies:9606
23028965	610	613	TTR	Gene	7276
23028965	739	742	TTR	Gene	7276
23028965	762	768	A-Beta	Gene	351
23028965	850	856	A-Beta	Gene	351
23028965	966	971	T119M	ProteinMutation	tmVar:p|SUB|T|119|M;HGVS:p.T119M;VariantGroup:1;CorrespondingGene:7276;CorrespondingSpecies:9606
23028965	972	975	TTR	Gene	7276
23028965	1241	1246	T119M	ProteinMutation	tmVar:p|SUB|T|119|M;HGVS:p.T119M;VariantGroup:1;CorrespondingGene:7276;CorrespondingSpecies:9606
23028965	1247	1250	TTR	Gene	7276
23028965	1280	1286	A-Beta	Gene	351
23028965	1287	1295	toxicity	Disease	MESH:D064420
23028965	1336	1339	TTR	Gene	7276
23028965	1419	1422	TTR	Gene	7276
23028965	1465	1469	TTR/	Gene	7276
23028965	1469	1475	A-Beta	Gene	351
23028965	1505	1519	iododiflunisal	Chemical	MESH:C504815
23028965	1521	1536	3-dinitrophenol	Chemical	-
23028965	1538	1549	resveratrol	Chemical	MESH:D000077185
23028965	1551	1580	[2-(3,5-dichlorophenyl)amino]	Chemical	-
23028965	1582	1586	DCPA	Chemical	MESH:C007220
23028965	1592	1616	[4-(3,5-difluorophenyl)]	Chemical	-
23028965	1618	1622	DFPB	Chemical	-
23028965	1646	1649	TTR	Gene	7276
23028965	1661	1667	A-Beta	Gene	351
23028965	1682	1686	DCPA	Chemical	MESH:C007220
23028965	1691	1695	DFPB	Chemical	-
23028965	1705	1708	TTR	Gene	7276
23028965	1731	1740	Thyroxine	Chemical	MESH:D013974
23028965	1744	1747	TTR	Gene	7276
23028965	1774	1777	TTR	Gene	7276
23028965	1778	1784	A-Beta	Gene	351
23028965	1801	1807	A-Beta	Gene	351
23028965	1823	1826	TTR	Gene	7276
23028965	1836	1839	RBP	Gene	57794
23028965	1849	1852	TTR	Gene	7276
23028965	1916	1919	TTR	Gene	7276
23028965	1988	1993	T119M	ProteinMutation	tmVar:p|SUB|T|119|M;HGVS:p.T119M;VariantGroup:1;CorrespondingGene:7276;CorrespondingSpecies:9606
23028965	1994	1997	TTR	Gene	7276
23028965	2051	2057	A-Beta	Gene	351
23028965	2086	2089	TTR	Gene	7276
23028965	2152	2154	AD	Disease	MESH:D000544
23028965	2202	2205	TTR	Gene	7276
23028965	Negative_Correlation	MESH:D064420	7276
23028965	Association	MESH:D064420	HGVS:p.T119M;CorrespondingGene:7276
23028965	Association	MESH:D000544	7276
23028965	Positive_Correlation	MESH:C504815	7276
23028965	Association	MESH:C007220	351
23028965	Negative_Correlation	351	7276
23028965	Association	MESH:D000077185	351
23028965	Association	MESH:D000077185	7276
23028965	Association	MESH:C504815	351
23028965	Positive_Correlation	MESH:C007220	7276
23028965	Association	MESH:D064420	7276

